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Abstract
Background: Bergström needle biopsy is widely used to sample skeletal muscle in order to study cell signaling
directly in human tissue. Consequences of the biopsy protocol design on muscle protein quantity and quality
remain unclear. The aim of the present study was to assess the impact of different events surrounding biopsy
protocol on the stability of the Western blot signal of eukaryotic translation initiation factor 4E binding protein 1
(4E-BP1), Akt, glycogen synthase kinase-3b (GSK-3b), muscle RING finger protein 1 (MuRF1) and p70 S6 kinase (p70
S6K). Six healthy subjects underwent four biopsies of the vastus lateralis, distributed into two distinct visits spaced
by 48 hrs. At visit 1, a basal biopsy in the right leg was performed in the morning (R1) followed by a second in the
left leg in the afternoon (AF). At visit 2, a second basal biopsy (R2) was collected from the right leg. Low intensity
mobilization (3 × 20 right leg extensions) was performed and a final biopsy (Mob) was collected using the same
incision site as R2.
Results: Akt and p70 S6K phosphorylation levels were increased by 83% when AF biopsy was compared to R1.
Mob condition induced important phosphorylation of p70 S6K when compared to R2. Comparison of R1 and R2
biopsies revealed a relative stability of the signal for both total and phosphorylated proteins.
Conclusions: This study highlights the importance to standardize muscle biopsy protocols in order to minimize
the method-induced variation when analyzing Western blot signals.
Background
Skeletal muscle atrophy is a common clinical compo-
nent of numerous diseases including AIDS, cancer,
chronic heart failure, chronic obstructive pulmonary dis-
ease, and diabetes [1-3]. Muscle atrophy has a wide
spectrum of consequences for chronically ill patients,
ranging from an aggravated morbidity to a seriously
impaired survival prognostic [4,5]. Since there is cur-
rently no effective treatment for atrophy [6], there is a
crucial need for a clear comprehension of muscle deple-
tion at the molecular level.
Fundamentally, muscle mass maintenance relies on a
tight regulation of protein synthesis and degradation,
two fundamental processes influenced by numerous sig-
naling pathways. The phosphatidylinositol-3 kinase/Akt
pathway has been pointed out as a key coordinator of
synthesis and degradation. Akt, the central protein of
this pathway, is an upstream kinase to several targets
implicated in both processes [7,8]. With the discovery of
the muscle-specific E3 ligases Muscle RING finger 1
(MuRF1) and Muscle Atrophy F-box in 2001 [9], the
ubiquitin-proteasome pathway has also emerged as an
important putative player in the atrophying process.
Historically, these two pathways have been predomi-
nantly investigated in cells and animal models. However,
to ascertain consistency with human muscle biology,
these pathways have been repeatedly studied directly in
human samples [10,11].
Human muscle samples required for biochemical stu-
dies have been obtained repeatedly with a Bergström
biopsy needle [12]. A concern with this technique is the
potential introduction of variability in studied para-
meters because of sampling site selection. Furthermore,
protein levels and/or their associated activities (kinase
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exercise [13] and nutritional state [14]. In the context of
studies aimed at investigating cell signaling in muscle
tissue, it cannot be excluded that sampling site variation
combined to unstandardized nutritional and physical
activity status could impact data analysis.
Western blotting is broadly used to dissect cell signal-
ing from muscle samples obtained by needle biopsies.
This technique provides precious pieces of information
on protein content or phosphorylation levels in a given
sample. As cell signaling is a vast and complex domain,
optimal confidence in results obtained by Western blot-
ting is essential to appropriately answer experimental
questions and to accurately angle future research
hypothesis. Thus, the aim of this study was to document
the impact of experimental conditions surrounding
human vastus lateralis biopsy procedures on the varia-
bility of the Western blot signals. Both total and phos-
phorylated forms of key proteins of the PI3K/Akt (i.e.
Akt, eukaryotic translation initiation factor 4E binding
protein 1 [4E-BP1], Glycogen synthase kinase-3 beta
[GSK-3b], p70 S6 kinase [p70 S6K]) and the ubiquitin-
proteasome (i.e. MuRF1) pathways were investigated.
Specifically, the present study was designed to answer
three questions: 1) What is the intrinsic variability
induced by the Bergström needle biopsy on muscle cell
signaling when successive biopsies are performed on
separate days? 2) Is performing skeletal muscle biopsies
at different periods in a given day induces variability in
the signal detection? 3) Does a low intensity mobiliza-
tion, such as walking or stair climbing, induces variabil-
ity in the signal detection? To properly answer these
q u e s t i o n s ,as p e c i f i cs e q u e n c eo ff o u rm u s c l eb i o p s i e s
was designed. First, two identical basal biopsies, spaced
by 48 hours, were performed in the morning in rested
and fasted subjects (R1 and R2). Next, a biopsy was per-
formed in the afternoon (AF) of the first day after R1.
Finally, the fourth biopsy was taken right after a low-
intensity mobilization (Mob), which was performed
immediately after the basal state biopsy (R2). These time
points likely represent common daily circumstances
faced by investigators when human muscle biopsies is
being included in the research protocol. We hypothe-
sized that the combined effects of a variable period of
the day or light mobilization will induce variability in
the Western blot signals in total and phosphorylated
proteins when compared to a rested and fasted state.
Methods
Subjects and Ethics Statement
Six healthy males aged between 26 and 45 years volun-
teered to participate in the study. These individuals
were free of any medication. All subjects were moder-
ately active (3-5 hrs of physical activity/week) and the
body mass index of the cohort was 23.5 ± 1.1 (mean ±
SEM). The Clinical Research Ethics Committee of the
“Institut Universitaire de Cardiologie et de Pneumologie
de Québec” approved the study protocol and each
patient signed a written informed consent form.
Study design
The study protocol required two distinct visits, each
including two biopsies. At the first visit, subjects arrived
at the laboratory between 8 and 9 AM after a 12-hours
fasting period. Subjects had to rest for 15 min and were
questioned about their activities in the last 24 hours.
This interview was performed to ensure that no sus-
tained exercise period occurred before the protocol. The
first biopsy of the right vastus lateralis was performed
under local anesthesia (2cc lidocaine 2%) using the
Bergström method [12], 15 cm above the patella, as rou-
tinely done in our laboratory [15]. This biopsy was iden-
tified as “rested and fasted-1” (R1). Subjects were then
invited to resume their typical daily activities without
any food restriction until 2 PM, when they had to return
for the next sample collection. Knowing that muscle
biopsies can be performed at any time of the day,
depending on the availability of the research subject and
the medical staff, we avoid any restriction in feeding and
mobilization after the first biopsy (R1). This format
allowed us to collect the second biopsy (AF) and to
answer the second research question of this study. Sub-
jects rested for 15 min and the second needle biopsy
was performed on the left vastus lateralis, 15 cm above
the patella. The second visit took place 48 hours later.
As for the initial visit, subjects arrived between 8 and 9
AM after a 12-hours fasting period and rested for 15
min. The third needle biopsy was then performed on
the right vastus lateralis, 3 cm above the first biopsy
site and away from the healing tissue. This biopsy was
identified as “rested and fasted-2” (R2). Immediately
after this biopsy, a temporary bandage was applied on
the site of incision and subjects had to perform 3 sets of
20 leg extensions while a 5-kg weight was applied over
the distal end of the right leg. The fourth biopsy was
collected immediately after this local mobilization
through the same incision that was used for the third
one. This biopsy was identified as “acute mobilization
and fasted” (Mob) and allowed us to answer the third
question of this study. Elapsed time between third and
fourth biopsies was less than 15 minutes. After each
biopsy, muscle specimens were cleaned with an absor-
bent tissue to remove blood before being snap frozen in
liquid nitrogen and kept at -80°C for future analyses.
Muscle protein extraction
To ensure maximal blood contaminant removal from
samples, approximately 50 mg of muscle was placed in
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Page 2 of 91 ml ice-cold PBS 1X and lightly agitated by hand for 45
seconds. The muscle specimen was recovered and
immediately placed in 500 μl ice-cold lysis buffer [5 mM
Tris-HCl pH 8.0, 1 mM EDTA, 1 mM EGTA, 1% gly-
cerol, 1 mM b-mercaptoethanol, protease inhibitor
cocktail set III (EMD biosciences), phosphatase inhibitor
cocktails 1 and 2 (Sigma-Aldrich)] and homogenized on
ice with a Polytron
® homogenizer. The resulting extract
was centrifuged (13 000 rpm, 4°C, 5 min) and the super-
natant was transferred to a new tube. An aliquot was
reserved for Bradford protein assay and Laemmli buffer
was added to the extract. Protein extract was then
boiled for 10 min, aliquoted and kept at -80°C for
further analyses.
Western blotting
To control for the non-linear relationship between pro-
tein quantity and Western blot signal, we loaded on
each gel serial quantities of a standardized protein
extract, in order to create a calibration curve, as sug-
gested by Charette et al [16]. The standardized protein
extract was obtained from 90% confluent human pri-
mary myoblats of a healthy subject. These cells were
washed once in ice-cold PBS before being scrapped in
300 μl Laemmli buffer. Cell extract was then boiled for
10 min and kept at -80°C. Western blots were per-
formed in duplicate with 10-30 μg total proteins using
standard SDS-PAGE procedures. Following transfer
onto nitrocellulose membrane, blotting was completed
with the following antibodies from Cell Signaling Tech-
nology (Danvers, MA, USA): anti-phospho-4E-BP1
(#2855, 1:1000), anti-Akt (#9272, 1:2000), anti-phospho-
Akt (#9271S, 1:1000), anti-GSK-3b (#9315, 1:1000), anti-
phospho-GSK-3b (#9331, 1:1000), anti-MuRF1 (#4305S,
1:1000), anti-p70 S6K (#9202, 1:1000), anti-phospho-p70
S6K (#9206S, 1:1000). Proteins of interest were detected
using a secondary antibody coupled to horseradish per-
oxidase (#7074, #7076, 1:5000, Cell Signaling Technol-
ogy). To ensure equal loading, every result was
normalized to tubulin (T5168, 1:20 000, Sigma-Aldrich,
St-Louis, MO, USA).
Western blot analysis
Specific protein abundance and phosphorylation levels
were analyzed as illustrated in Figure 1. For a given sub-
ject, his four muscle extracts were loaded onto a gel,
along with a dilution series of the protein extract
obtained from human myoblasts (Figure 1, panel A).
Densitometry of the resulting bands was obtained using
ImageJ software [17]. Using data from the dilution ser-
ies, a calibration curve was plotted (protein extract
volume against Western blot signal) and the Western
blot signal obtained for all the biopsies of a given indivi-
dual were reported on this curve as illustrated in Figure
1, panel B. The corresponding volume of protein extract
for each Western blot signal was determined and con-
sidered as standardized data, as shown in Figure 1,
panel C. To control for protein loading, standardized
data were reported on tubulin Western blot signal and
these corrected values were used for subsequent com-
parative analyses.
Statistical analysis
Data are presented as mean ± standard error of the
mean (SEM). R1 was set as the referential value and
absolute variations of either AF or R2 samples were
reported against this condition. These comparisons were
performed to assess the repeatability of the measure
(question 1: R1 vs R2) and the impact of feeding and
daily activities (question 2: R1 vs AF) on cell signaling.
Figure 1 Western blot analysis strategy exemplified for
phospho-Akt. A) To control for the non-linearity between Western
blot signal and the amount of protein loaded, a dilution series of
protein extracts obtained from human primary myoblasts was
loaded on every gel in order to build a calibration curve. B) Each
volume of myoblasts protein extract was plotted against their
optical density. Optical densities of subject’s muscle extracts were
then reported on the calibration curve and the corresponding
volume of protein extract was found. C) These data were
considered the standardized values and were used for the final
analysis. p-Akt = phospho-Akt
Caron et al. BMC Research Notes 2011, 4:488
http://www.biomedcentral.com/1756-0500/4/488
Page 3 of 9A sub-analysis was also performed, where R2 was set as
the referential value and compared to Mob condition, in
order to measure the impact of a local acute mobiliza-
tion on protein expression and activity levels as evi-
denced by phosphorylation level variations (question 3).
In all analyses, each subject was used as its own control.
The intrinsic variability produced by the entire Western
blot technique was evaluated by calculating the mean
standardized signal variation of every duplicate per-
formed for this study. By using this method, a techni-
que-induced variability of 32% on the measure was
found. The inter-measures concordance was evaluated
by performing Pearson correlations between Western
blot signals for Akt, GSK-3b, MuRF1 and p70 S6K using
R2 and Mob biopsies. P-value < 0.05 was considered sta-
tistically significant.
Results
Total protein amount variation
The impact of the conditions surrounding biopsy proce-
dures on total protein amount was evaluated by measur-
ing the intra-subject variation of the Western blot signal
obtained with each sampling conditions (R1, AF, R2,
Mob). In our hands, the technique-induced variability
was assessed to be 28% for the 4 total proteins tested
(Table 1). Two separate analyses were performed with
each protein. First, as depicted on the left side of Figure
2, relative differences in Western signal between biopsy
conditions are expressed as actual mathematical varia-
tions. Thus, positive and negative variations are reported
for all six subjects. In order to abrogate the effect of
combining positive and negative values in mean calcula-
tion and to reflect the proper fluctuation induced by
sampling conditions, absolute variation values were also
calculated. Results are presented on the right side of
Figure 2. Using this second analysis, GSK-3b protein
level was found to be the most stable, with a range of
variation between 24% for rest vs acute mobilization
conditions (R2 vs Mob) and 31% for rest and fasted vs
active and fed conditions (R1 vs AF). On the opposite,
MuRF1 was the most fluctuating protein, reaching a
maximal variation level of 60% over two biopsies taken
in similar conditions 48 hours apart (R1 vs R2). For all
four conditions compared, Akt signal variations were
approximately 30%. In a similar way, p70 S6K protein
level variations ranged from 25% (R1 vs AF) to 37% (R1
vs R2). In all studied proteins, signal comparison of
both biopsies taken at rest and in fasted state (R1 vs R2)
revealed a range of variation between 28% (Akt and
GSK-3b) and 60% (MuRF1). Similarly, a global analysis
of all the protein levels uncovered a variation ranging
between 25% (p70 S6K) and 47% (MuRF1) for biopsies
taken at two selected time points during a given day (R1
vs AF). When comparing signals obtained with two suc-
cessive biopsies (R2 and Mob), the variation recorded
was constantly one of the lowest in all four tested pro-
teins, ranging from 20% (Akt) to 31% (MuRF1).
Western blot signal concordance obtained with two
successive muscle biopsies (R2 and Mob) was assessed
using Pearson correlations. Strong positive correlations
were found for Akt (r = 0.8045), GSK-3b (r = 0.9435)
and p70 S6K (r = 0.8551) whereas the correlation was
moderate in the case of MuRF1 (r = 0.6059).
Phosphorylation state variation
In a second set of analyses, we tested the impact of
muscle sampling conditions (rest, activity/feeding and
acute mobilization) on the phosphorylation state of key
proteins related to muscle mass homeostasis. In our
hands, the technique-induced variability was assessed to
be 37% for the 4 phosphorylated proteins tested (Table
1). As presented with total proteins, phosphorylated pro-
teins were analyzed both with actual and absolute values
and the results are shown in Figure 3 (left and right side
of the figure, respectively). As depicted on the right side
of the figure, Western blot signal variability of phos-
phorylated Akt ranged from 26% between both rest and
fasted conditions (R1 vs R2) to 83% between rest and
fasted vs activity and fed conditions (R1 vs AF). GSK-3b
and 4E-BP1 phosphorylation levels reached respectively
variations of 19% (R1 vs AF) to 54% (R2 vs Mob) and
23% (R1 vs R2) to 39% (R1 vs AF). Phosphorylation
state of p70 S6K reached a variation level of 299% when
the acute mobilization (Mob) signals were compared to
the rest and fasted condition (R2). Global analysis of the
results reveals that R1/R2 comparison induced fluctua-
tions of the signal ranging from 23% (phospho-4E-BP1)
to 51% (phospho-p70 S6K). A spectrum of variation,
ranging from 19% (phospho-GSK-3b) to 83% (phospho-
Akt and phospho-p70 S6K), was found when the signals
Table 1 Western blot technique-induced variability of the
duplicates per protein.
Protein tested Technique-induced variability
Akt 27%
phospho-Akt 25%
GSK-3b 26%
phospho-GSK-3b 25%
p70 S6K 20%
phospho-p70 S6K 50%
MuRF1 37%
phospho-4E-BP1 48%
Total proteins 28%
Phospho-proteins 37%
Overall 32%
4E-BP1, eukaryotic translation initiation factor 4E binding protein 1; GSK-3b,
Glycogen synthase kinase-3 beta; p70 S6K, p70 S6 kinase; MuRF1, Muscle
RING finger 1.
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Page 4 of 9Figure 2 Muscle biopsy conditions induce minimal to moderate variability on total proteins Western blot signal. All biopsies of each
subject were blotted against Akt, GSK-3b, MuRF1 and p70 S6K. Standardized value for every band optical density was obtained and protein
expression level between biopsy conditions were compared. All results were normalized with tubulin signal to ensure equal loading. Data are
expressed in percentage of variation between two biopsy situations. On the left side, data are expressed as real values where positive and
negative variation levels are depicted. The vertical line represents the mean variation level. On the right side, every difference between
compared biopsies was transformed in absolute values, so that no distinction was made between an increase and a decrease in protein
expression between two conditions. Results are expressed as mean ± SEM of 6 intra-subject variations.
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Page 5 of 9Figure 3 Akt, GSK-3b, 4E-BP1 and p70 S6K phosphorylation levels are influenced by muscle biopsy conditions. All biopsies of each
subject were blotted against phospho-Akt, phospho-GSK-3b, phospho-4E-BP1, phospho-p70 S6K. Standardized value for every band optical
density was obtained and protein expression level between biopsy conditions were compared as shown in bar graphs. All results were
normalized with tubulin signal to ensure equal loading. Data are expressed in percentage of variation between two biopsy situations. On the left
side, data are expressed as real values where positive and negative variation levels are depicted. The vertical line represents the mean variation
level. On the right side, every difference between compared biopsies was transformed in absolute values, so that no distinction was made
between an increase and a decrease in protein expression between two conditions. Results are expressed as mean ± SEM of 6 intra-subject
variations. p- = phosphorylated
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Page 6 of 9of activity and fed (AF) and rest and fasted (R1) condi-
tions were compared. The protein phosphorylation com-
parisons of the second rest and fasted (R2) to the acute
mobilization (Mob) conditions revealed variations ran-
ging from 32% (phospho-4E-BP1) to 299% (phospho-
p70 S6K). Finally, when analyzing the data expressed in
actual values (Figure 3, left side), activity and fed condi-
tion (AF) exclusively induced positive Akt phosphoryla-
tion changes when Western blot signals were compared
to R1. Similarly, acute mobilization condition (Mob)
exclusively induced positive changes in p70 S6K phos-
phorylation state when signals were compared to the
second rest and fasted condition (R2).
Discussion
This study provides a quantitative measurement on the
impact of experimental conditions when multiple Berg-
ström needle biopsies are performed to study cell signal-
ing in human muscle tissue using Western blotting. As
other laboratory techniques, Western blot exhibits an
inherent variability that is difficult to precisely evaluate.
However, using triplicata of a given sample on a single
gel, it has been estimated that Western blotting alone
produces a coefficient of variation of approximately 10%
[18]. Since assessment in triplicata implies that the same
protein extract is used, the reported 10% variation does
not take into account the additional variability that
could be induced by protein extraction protocol and
dosage. In our hands, the technique-induced variability
was higher with phosphorylated proteins and the overall
variability was assessed to be 32% (Table 1). Our dupli-
cates were run onto two distinct gels instead of being
on the same gel, likely explaining the higher variation in
this study compared to the one previously cited [18].
This intrinsic 32% variation level was used as a guideline
to weigh against the subsequent variation levels obtained
in the present study.
Different patterns of variation were observed when
total protein was considered. First observation, GSK-3b
was found to be almost insensitive to muscle biopsy
conditions. A second pattern was observed with Akt and
p70 S6K. With a maximal variation level reaching 35%,
total Akt exhibited a low amplitude response to every
sampling conditions tested in the present protocol. Akt
is a central kinase and interacts with an impressive
number of partners [19]. This implies that at every
moment, numerous intra- and extra-cellular signals reg-
ulate its kinase activity level. Thus, in a context of
extensive regulation, a ~30% variation in the measure-
ment of the total form of Akt is minimal, especially
when assuming that the technique induced variability is
32% in our hands. This result possibly reflects the need
of a strong stimulus, like sepsis for instance, to induce a
noticeable regulation of Akt quantity [20,21]. Similarly
total p70 S6K signal was not extensively affected by
biopsy conditions. A third variation pattern was
observed with MuRF1 protein. Moderate fluctuations
reaching 31 to 60% in response to acute mobilization
and activities were measured. These values are up to
two fold higher than the variation level associated with
the technique itself. Except for its induction in atrophied
muscle [9,22], the regulation of MuRF1 is still unclear.
Nonetheless, a difference of 60% in the signal of MuRF1
between two biopsies taken in similar conditions (R1
and R2) demonstrates that minor modifications in sub-
ject behavior can have a significant impact on its expres-
sion level. Strict and fast protein quantity regulation can
be observed with particular proteins such as hypoxia
inducible factor-1 alpha, the latter being rapidly marked
and degraded by the ubiquitin-proteasome pathway in
presence of oxygen (half-life < 5 min) [23]. MuRF1
accumulation is increased by energy deprivation condi-
tions [24] and hyperinsulinemia [25]. Since subjects
were fasted prior to the first biopsy (R1) and allowed to
feed and move before the biopsy performed in the after-
noon of the same day (AF), it might be argued that
nutritional status could explain the variation of 47%
observed in this particular situation. However, since
positive and negative regulations are observed between
R1 and AF biopsies, other unknown factors are probably
influencing its level. MuRF1 being a key component of
the ubiquitin-proteasome pathway with specific targeted
proteins [26], it is conceivable that its level constantly
fluctuates over time depending on the surrounding pool
of intracellular proteins to be degraded.
In muscle tissue, protein phosphorylation is a rapid
and well-described cellular response to numerous sti-
muli including inflammation [27], exercise [28] and
nutrition [14]. Given the relative unsteadiness of protein
phosphorylation levels, a wide range of variations was
expected with phosphorylated protein measurement in
this study. Even though Akt phosphorylation was rela-
tively stable in most conditions, a variation of 83%
between fasted and fed conditions (R1 vs AF) was
observed. This situation is in agreement with the
increased phosphorylation of Akt observed in skeletal
muscle when systemic insulin is administered [29]. Con-
sidering the experimental design, it is difficult to discri-
minate between the feeding state and daily activities
since neither was controlled between both R1 and AF
biopsies. Nevertheless, this observation highlights the
notion of standardizing the biopsy protocol in order to
minimize fluctuation in the signal due to sampling tech-
nique when multiple biopsies are needed in the research
protocol. Based on these considerations and as detailed
in this study, we emphasize on the notion that the
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study should be clearly reported in the method section
of every publication.
Mobilization was also found to be an important phos-
phorylation modulator of phospho-p70 S6K and, to a
lesser extent, of phospho-GSK-3b. Since the prescribed
mobilization in this study was of relatively low intensity
for young healthy subjects, the impact of mobilization
(stairs or walking) for elderly and/or diseased patients
has the potential to create a similar impact as the one
observed in the current protocol. Based on our results,
it is clear that physical activity, even of a low level,
should be avoided before sampling muscle tissue if a
study is designed to analyze basal phosphorylation
signals.
Interestingly, the two highest inter-biopsy variations
found in the present study (phospho-Akt, R1 vs AF;
phospho-p70 S6K, R2 vs Mob) were the only compari-
sons where all subjects uniformly responded with an
increase in phosphorylation level to the stimulus. Since
the interventions were of relatively low intensity, this
implies that any physiological divergent event in a given
protocol has the potential to alter muscle protein signal-
ing and to induce false positive or negative results in
Western blot based analysis. On the other hand, com-
parison of the two basal conditions (R1 and R2) system-
atically emerged as one of the most stable for all
phosphorylated proteins tested in this study. This indi-
cates that, despite the relative instability of protein
phosphorylation state, taking simple precautions can cir-
cumvent unsolicited situations as observed for phospho-
Akt and phospho-p70 S6K.
As this study was performed with human subjects, a
small number of methodological considerations were
taken into account when planning the protocol. Because
Bergström needle biopsy is a relatively invasive techni-
que, we choose to perform the afternoon biopsy (AF) on
the left vastus lateralis in order to minimize subject’s
discomfort, given the fact they already underwent a
biopsy procedure on the right leg the very same morn-
ing (R1 biopsy). The impact of leg change on protein
variation is unknown. However, results obtained when
comparing R1 and AF biopsies did not particularly fluc-
tuate in terms of amplitude when put side by side to the
other comparisons done fort h es a m ep r o t e i n .T h i s
observation suggests that the change of sampled leg did
not, by itself, induce a major bias, although the real
impact cannot be clearly measured. Also, the second
basal biopsy (R2) was collected approximately 3 cm over
the first basal (R1) and it could be speculated that an
inflammatory response occurred at the second sampling
site in reaction to the first injury. Nevertheless, no
macroscopic observation leads us to recognize that such
a phenomenon was occurring at the time of the R2
biopsy. Despite our efforts to reduce subject discomfort,
we experienced some difficulties in recruiting volunteers
to undertake such an invasive trial. The net result of the
low number of subjects was a decreased sensitivity to
detect variability between sampling conditions. Finally, it
cannot be excluded that a healing or trauma effect was
occurring between R2 and Mob biopsies. Although the
exact effects of these processes on post-transcriptional
modifications are unknown, this could explain in part
the differences found in the phosphorylation levels of
p70 S6K and GSK-3b between these two conditions.
Conclusion
In conclusion, this study clearly demonstrates that
unstandardized human muscle sampling protocols can
alter the final answer obtained when Western blotting is
performed to measure a specific response. This state-
ment is particularly true when protein phosphorylation
is the signal being assessed. Our data suggest that phos-
phorylation of Akt and p70 S6K might be affected by
nutritional status and activity. Accordingly, scientists
investigating these proteins in muscle biopsies should be
aware of these findings during design of the study and
interpretation of the results, particularly in situations in
which changes in protein level/phosphorylation are of
lower magnitude. Finally, it cannot be excluded that
other phosphorylated proteins or other post-transla-
tional processes (glycosylation, methylation) could react
in a similar manner when unstandardized sampling pro-
tocol is used.
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